Breaking News Instant updates and real-time market news.

ATNX

Athenex

$14.56 /

-2.38 (-14.05%)

07:09
12/16/19
12/16
07:09
12/16/19
07:09

Athenex expands strategic partnership with Guangzhou Xiangxue Pharmaceutical

Athenex announced that it has expanded its strategic partnership with Chinese drug company, Guangzhou Xiangxue Pharmaceutical, to exclusively develop and commercialize Athenex's oncology product candidates Oral Paclitaxel, Oral Irinotecan, as well as Tirbanibulin Ointment, including for the treatment of actinic keratosis in the Territory. Under the terms of the license agreement, subject to the satisfaction of certain conditions, Athenex will receive an upfront payment of $30M. Athenex will also be eligible to receive development, sales and other milestone payments up to $170M, and tiered royalties ranging from the sub-teen to low twenties based on annual net sales of licensed products in the Territory and a percentage of sublicensing revenue. The total deal size is potentially $200M, excluding the royalty payments. The agreement provides for joint decision making through a Joint Steering Committee with respect to the development and commercialization of the licensed products in the Territory. Athenex and Xiangxue will jointly lead the clinical development programs with Athenex to coordinate the global drug development efforts while Xiangxue will oversee commercialization activities in the Territory. The Orascovery platform was initially developed by Hanmi Pharmaceuticals and licensed exclusively to Athenex for all major worldwide territories except Korea, which is retained by Hanmi. Athenex has an exclusive license agreement with Almirall, S.A. to the rights to tirbanibulin ointment in the following territories: USA, European Union, Russia and Turkey. Details of this arrangement were disclosed in December 2017.

ATNX Athenex
$14.56 /

-2.38 (-14.05%)

12/13/19 RBC Capital
Athenex oraxol OS and ORR a 'best case,' buy on weakness, says RBC Capital
12/06/19 Truist
Athenex initiated with a Buy at SunTrust
11/19/19 RBC Capital
Athenex gets 'third SABCS win' ahead of meeting, says RBC Capital
08/07/19 RBC Capital
Athenex's Oraxol data 'near best-case,' says RBC Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Nurix appoints Robert Tjian as chairman of Scientific Advisory Board » 08:39
10/26/20
10/26
08:39
10/26/20
08:39
NRIX

Nurix Therapeutics

$28.21 /

+0.76 (+2.77%)

Nurix Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRIX Nurix Therapeutics
$28.21 /

+0.76 (+2.77%)

08/18/20
Fly Intel: Top five analyst initiations
08/18/20 JPMorgan
Nurix Therapeutics initiated with an Overweight at JPMorgan
08/18/20 Needham
Nurix Therapeutics initiated with a Buy at Needham
08/18/20 Stifel
Nurix Therapeutics initiated with a Buy at Stifel
NRIX Nurix Therapeutics
$28.21 /

+0.76 (+2.77%)

  • 24
    Jul
NRIX Nurix Therapeutics
$28.21 /

+0.76 (+2.77%)

Recommendations
Pinterest price target raised to $57 from $37 at JPMorgan » 08:38
10/26/20
10/26
08:38
10/26/20
08:38
PINS

Pinterest

$52.99 /

+2.19 (+4.31%)

JPMorgan analyst Doug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$52.99 /

+2.19 (+4.31%)

PINS Pinterest
$52.99 /

+2.19 (+4.31%)

07:17 Today KeyBanc
Pinterest price target raised to $60 from $44 at KeyBanc
10/22/20 OTR Global
Pinterest upgraded to Positive from Mixed at OTR Global
10/21/20
Fly Intel: Top five analyst upgrades
10/21/20 Goldman Sachs
Pinterest upgraded to Buy from Neutral at Goldman Sachs
PINS Pinterest
$52.99 /

+2.19 (+4.31%)

PINS Pinterest
$52.99 /

+2.19 (+4.31%)

PINS Pinterest
$52.99 /

+2.19 (+4.31%)

PINS Pinterest
$52.99 /

+2.19 (+4.31%)

Hot Stocks
Resverlogix announces publication on apabetalone in Medicine in Drug Discovery » 08:38
10/26/20
10/26
08:38
10/26/20
08:38

Resverlogix announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Huntington Bancshares upgraded to Outperform at Wedbush » 08:38
10/26/20
10/26
08:38
10/26/20
08:38
HBAN

Huntington Bancshares

$10.47 /

+0.1 (+0.96%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HBAN Huntington Bancshares
$10.47 /

+0.1 (+0.96%)

HBAN Huntington Bancshares
$10.47 /

+0.1 (+0.96%)

07:10 Today Wedbush
Huntington Bancshares upgraded to Outperform from Neutral at Wedbush
07/31/20 Wolfe Research
Huntington Bancshares initiated with an Outperform at Wolfe Research
06/03/20 Stephens
Stephens upgrades Huntington Bancshares to Overweight on trends in key markets
06/03/20 Stephens
Huntington Bancshares upgraded to Overweight from Equal Weight at Stephens
HBAN Huntington Bancshares
$10.47 /

+0.1 (+0.96%)

HBAN Huntington Bancshares
$10.47 /

+0.1 (+0.96%)

HBAN Huntington Bancshares
$10.47 /

+0.1 (+0.96%)

HBAN Huntington Bancshares
$10.47 /

+0.1 (+0.96%)

Recommendations
Proofpoint price target lowered to $124 from $155 at DA Davidson » 08:37
10/26/20
10/26
08:37
10/26/20
08:37
PFPT

Proofpoint

$107.47 /

-0.96 (-0.89%)

DA Davidson analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFPT Proofpoint
$107.47 /

-0.96 (-0.89%)

PFPT Proofpoint
$107.47 /

-0.96 (-0.89%)

08/26/20 Wedbush
Proofpoint assumed with an Outperform at Wedbush
08/19/20
Fly Intel: Top five analyst upgrades
08/19/20 Morgan Stanley
Proofpoint upgraded to Overweight from Equal Weight at Morgan Stanley
07/31/20 Northland
Proofpoint price target raised to $153 from $145 at Northland
PFPT Proofpoint
$107.47 /

-0.96 (-0.89%)

Recommendations
JPMorgan continues to like top pick Amazon into Q3 results » 08:37
10/26/20
10/26
08:37
10/26/20
08:37
AMZN

Amazon.com

$3,203.69 /

+28.72 (+0.90%)

JPMorgan analyst Doug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

08:14 Today Bernstein
Bernstein looking at Q3 as an investment period for Amazon
10/20/20 Citi
Citi likes Amazon head of Q3 results despite Prime Day language
10/19/20 Piper Sandler
Amazon Prime Day sales up 49% year-over-year, says Piper Sandler
10/16/20 Citi
Citi questions if Amazon's Prime Day may disappoint compared to last year
AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

AMZN Amazon.com
$3,203.69 /

+28.72 (+0.90%)

Earnings
TriCo Bancshares reports Q3 EPS 59c, consensus 59c » 08:36
10/26/20
10/26
08:36
10/26/20
08:36
TCBK

TriCo Bancshares

$30.42 /

+0.01 (+0.03%)

Reports Q3 book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCBK TriCo Bancshares
$30.42 /

+0.01 (+0.03%)

Upgrade
Live Oak Bancshares upgraded to Strong Buy from Outperform at Raymond James » 08:36
10/26/20
10/26
08:36
10/26/20
08:36
LOB

Live Oak Bancshares

$33.68 /

+0.69 (+2.09%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LOB Live Oak Bancshares
$33.68 /

+0.69 (+2.09%)

LOB Live Oak Bancshares
$33.68 /

+0.69 (+2.09%)

08:23 Today Truist
Live Oak Bancshares price target raised to $43 from $28 at Truist
06:29 Today Raymond James
Live Oak Bancshares upgraded to Strong Buy from Outperform at Raymond James
09/29/20
Fly Intel: Top five analyst initiations
09/29/20 Raymond James
Live Oak Bancshares initiated with an Outperform at Raymond James
LOB Live Oak Bancshares
$33.68 /

+0.69 (+2.09%)

LOB Live Oak Bancshares
$33.68 /

+0.69 (+2.09%)

Hot Stocks
Hudbay Minerals provides update on inspection of 777 mine » 08:36
10/26/20
10/26
08:36
10/26/20
08:36
HBM

Hudbay Minerals

$5.11 /

+0.035 (+0.69%)

Hudbay Minerals provides…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HBM Hudbay Minerals
$5.11 /

+0.035 (+0.69%)

HBM Hudbay Minerals
$5.11 /

+0.035 (+0.69%)

10/22/20 National Bank
Hudbay Minerals price target raised to C$7 from C$6.75 at National Bank
10/13/20 Scotiabank
Hudbay Minerals price target raised to C$7.25 from C$5 at Scotiabank
10/13/20 Scotiabank
Hudbay upgraded to Outperform on copper leverage at Scotiabank
10/13/20 Scotiabank
Hudbay Minerals upgraded to Outperform from Sector Perform at Scotiabank
HBM Hudbay Minerals
$5.11 /

+0.035 (+0.69%)

Conference/Events
The SEC to hold a virtual roundtable discussion » 08:36
10/26/20
10/26
08:36
10/26/20
08:36

The SEC staff and the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Granite Construction announces two airport projects totaling $15M » 08:35
10/26/20
10/26
08:35
10/26/20
08:35
GVA

Granite Construction

$20.30 /

+0.2 (+1.00%)

Granite announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GVA Granite Construction
$20.30 /

+0.2 (+1.00%)

GVA Granite Construction
$20.30 /

+0.2 (+1.00%)

06/25/20 DA Davidson
Granite Construction price target lowered to $17 from $30 at DA Davidson
01/13/20 Goldman Sachs
Granite Construction downgraded to Sell from Neutral at Goldman Sachs
10/28/19
Granite Construction downgraded to Neutral from Buy at DA Davidson
10/28/19 DA Davidson
Granite Construction downgraded to Neutral from Buy at DA Davidson
GVA Granite Construction
$20.30 /

+0.2 (+1.00%)

GVA Granite Construction
$20.30 /

+0.2 (+1.00%)

GVA Granite Construction
$20.30 /

+0.2 (+1.00%)

Hot Stocks
Collegium announces publication of postmarketing analysis of Xtampza ER » 08:35
10/26/20
10/26
08:35
10/26/20
08:35
COLL

Collegium Pharmaceutical

$19.37 /

+0.26 (+1.36%)

Collegium Pharmaceutical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COLL Collegium Pharmaceutical
$19.37 /

+0.26 (+1.36%)

COLL Collegium Pharmaceutical
$19.37 /

+0.26 (+1.36%)

07/14/20 BWS Financial
Collegium Pharmaceutical initiated with a Sell at BWS Financial
05/27/20 Guggenheim
Guggenheim starts coverage of four pain treatment makers with two Buys
05/26/20 Guggenheim
Collegium Pharmaceutical initiated with a Neutral at Guggenheim
03/23/20 SunTrust
SunTrust lowers price targets among Pharmaceuticals due to COVID-19
COLL Collegium Pharmaceutical
$19.37 /

+0.26 (+1.36%)

Initiation
Chindata initiated with an Overweight at Morgan Stanley » 08:35
10/26/20
10/26
08:35
10/26/20
08:35
CD

Chindata

$13.58 /

+0.03 (+0.22%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 30
    Sep
CD Chindata
$13.58 /

+0.03 (+0.22%)

Upgrade
First Midwest upgraded to Outperform from Market Perform at Raymond James » 08:34
10/26/20
10/26
08:34
10/26/20
08:34
FMBI

First Midwest

$12.59 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FMBI First Midwest
$12.59 /

+ (+0.00%)

FMBI First Midwest
$12.59 /

+ (+0.00%)

04:56 Today Raymond James
First Midwest upgraded to Outperform from Market Perform at Raymond James
03/06/20 SunTrust
First Midwest downgraded to Hold from Buy at SunTrust
FMBI First Midwest
$12.59 /

+ (+0.00%)

Recommendations
Netflix narrative to focus less on subs, more on profitability, says Wells Fargo » 08:34
10/26/20
10/26
08:34
10/26/20
08:34
NFLX

Netflix

$488.28 /

+3.01 (+0.62%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$488.28 /

+3.01 (+0.62%)

NFLX Netflix
$488.28 /

+3.01 (+0.62%)

10/21/20 JPMorgan
Netflix weakness on earnings a buying opportunity, says JPMorgan
10/21/20 KeyBanc
KeyBanc sees Netflix stock weakness as 'an overreaction'
10/21/20 Wells Fargo
Netflix price target raised to $510 from $470 at Wells Fargo
10/21/20 Canaccord
Netflix profits outperformed while subscriber growth slowed, says Canaccord
NFLX Netflix
$488.28 /

+3.01 (+0.62%)

NFLX Netflix
$488.28 /

+3.01 (+0.62%)

NFLX Netflix
$488.28 /

+3.01 (+0.62%)

NFLX Netflix
$488.28 /

+3.01 (+0.62%)

Hot Stocks
Liquid Media commercializes retro games, enters deal with Throwback » 08:34
10/26/20
10/26
08:34
10/26/20
08:34
YVR

Liquid Media

$1.65 /

-0.04 (-2.37%)

Liquid Media Group has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YVR Liquid Media
$1.65 /

-0.04 (-2.37%)

Initiation
Mission Produce initiated with an Overweight at JPMorgan » 08:34
10/26/20
10/26
08:34
10/26/20
08:34
AVO

Mission Produce

$13.24 /

-0.18 (-1.34%)

JPMorgan analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVO Mission Produce
$13.24 /

-0.18 (-1.34%)

06:25 Today Citi
Mission Produce initiated with a Buy at Citi
06:23 Today Stephens
Mission Produce initiated with an Overweight at Stephens
  • 01
    Oct
AVO Mission Produce
$13.24 /

-0.18 (-1.34%)

Hot Stocks
Spectrum Brands acquires pet treat and toy company, Armitage Pet Care » 08:34
10/26/20
10/26
08:34
10/26/20
08:34
SPB

Spectrum Brands

$60.54 /

-0.8 (-1.30%)

Spectrum Brands Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPB Spectrum Brands
$60.54 /

-0.8 (-1.30%)

10/05/20 Oppenheimer
Spectrum Brands price target raised to $68 from $58 at Oppenheimer
09/08/20 RBC Capital
Spectrum Brands price target raised to $80 from $62 at RBC Capital
07/16/20 Deutsche Bank
Spectrum Brands price target raised to $53 from $47 at Deutsche Bank
03/30/20 Oppenheimer
Spectrum Brands price target lowered to $50 from $80 at Oppenheimer
SPB Spectrum Brands
$60.54 /

-0.8 (-1.30%)

Hot Stocks
Keurig Dr Pepper: Snapple, CORE transition to 100% recycled plastic bottles » 08:33
10/26/20
10/26
08:33
10/26/20
08:33
KDP

Keurig Dr Pepper

$29.18 /

-0.37 (-1.25%)

Keurig Dr Pepper…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KDP Keurig Dr Pepper
$29.18 /

-0.37 (-1.25%)

KDP Keurig Dr Pepper
$29.18 /

-0.37 (-1.25%)

10/20/20 Jefferies
National Beverage upgraded to Hold on better La Croix market share at Jefferies
08/27/20 Jefferies
Keurig Dr Pepper has long runway for pod category growth, says Jefferies
08/26/20
Fly Intel: Top five analyst upgrades
08/26/20 Morgan Stanley
Keurig Dr Pepper upgraded to Overweight on coffee 'boost' at Morgan Stanley
KDP Keurig Dr Pepper
$29.18 /

-0.37 (-1.25%)

  • 18
    Aug
  • 03
    Aug
  • 21
    May
  • 05
    Mar
KDP Keurig Dr Pepper
$29.18 /

-0.37 (-1.25%)

General news
Chicago Fed National Activity Index data reported » 08:33
10/26/20
10/26
08:33
10/26/20
08:33

September Chicago Fed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Forte Biosciences receives fast track designation for FB-401 from FDA » 08:33
10/26/20
10/26
08:33
10/26/20
08:33
FBRX

Forte Biosciences

$35.37 /

+1.92 (+5.74%)

Forte Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FBRX Forte Biosciences
$35.37 /

+1.92 (+5.74%)

FBRX Forte Biosciences
$35.37 /

+1.92 (+5.74%)

09/24/20 Chardan
Forte Biosciences price target raised to $110 from $60 at Chardan
09/18/20 Chardan
Seres Therapeutics downgraded to Neutral from Buy at Chardan
09/10/20 Chardan
Forte Biosciences price target raised to $60 from $45 at Chardan
08/28/20 Chardan
Forte Biosciences upgraded to Buy from Neutral at Chardan
FBRX Forte Biosciences
$35.37 /

+1.92 (+5.74%)

FBRX Forte Biosciences
$35.37 /

+1.92 (+5.74%)

Upgrade
Crown Castle upgraded to Outperform from Market Perform at Raymond James » 08:33
10/26/20
10/26
08:33
10/26/20
08:33
CCI

Crown Castle

$158.54 /

+2.285 (+1.46%)

Raymond James analyst Ric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CCI Crown Castle
$158.54 /

+2.285 (+1.46%)

CCI Crown Castle
$158.54 /

+2.285 (+1.46%)

04:55 Today Raymond James
Crown Castle upgraded to Outperform from Market Perform at Raymond James
08/20/20
Fly Intel: Top five analyst downgrades
08/20/20 Wells Fargo
Wells Fargo downgrades Crown Castle on fiber, 2020 guidance risk
08/20/20 Wells Fargo
Crown Castle downgraded to Equal Weight from Overweight at Wells Fargo
CCI Crown Castle
$158.54 /

+2.285 (+1.46%)

CCI Crown Castle
$158.54 /

+2.285 (+1.46%)

Earnings
Wayne Savings Bancshares reports Q3 EPS 77c vs. 60c last year » 08:33
10/26/20
10/26
08:33
10/26/20
08:33
WAYN

Wayne Savings Bancshares

$17.55 /

+ (+0.00%)

President and CEO James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WAYN Wayne Savings Bancshares
$17.55 /

+ (+0.00%)

Initiation
Asana initiated with a Neutral at JPMorgan » 08:33
10/26/20
10/26
08:33
10/26/20
08:33
ASAN

Asana

$23.51 /

-0.48 (-2.00%)

JPMorgan analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

08:08 Today KeyBanc
Asana initiated with a Sector Weight at KeyBanc
07:53 Today Oppenheimer
Asana initiated with an Outperform at Oppenheimer
07:51 Today Morgan Stanley
Asana initiated with an Equal Weight at Morgan Stanley
07:33 Today Credit Suisse
Asana initiated with a Neutral at Credit Suisse
ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

ASAN Asana
$23.51 /

-0.48 (-2.00%)

Hot Stocks
Aeglea BioTherapeutics' ACN00177 for homocystinuria designated Orphan Drug » 08:32
10/26/20
10/26
08:32
10/26/20
08:32
AGLE

Aeglea BioTherapeutics

$7.66 /

-0.4 (-4.96%)

Aeglea…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGLE Aeglea BioTherapeutics
$7.66 /

-0.4 (-4.96%)

AGLE Aeglea BioTherapeutics
$7.66 /

-0.4 (-4.96%)

08/10/20 Piper Sandler
Piper Sandler backs Overweight rating on Aeglea BioTherapeutics after Q2 results
05/04/20
Fly Intel: Top five analyst initiations
05/04/20 Piper Sandler
Aeglea BioTherapeutics initiated with an Overweight at Piper Sandler
04/30/20 H.C. Wainwright
Aeglea BioTherapeutics price target lowered to $18 from $24 at H.C. Wainwright
AGLE Aeglea BioTherapeutics
$7.66 /

-0.4 (-4.96%)

  • 28
    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.